Credits: Canva
A chronic skin condition that causes dry, itchy patches of thickened skin. It is both frustrating and debilitating. By now you may now what we are talking about. It is Eczema. While there is no definitive cure for Eczema, there are studies that highlight the potential of self-guided talk therapy that can actually alleviate its symptoms.
Eczema can flare up if you contact an irritant or an allergen. This condition weakens your skin's barrier function which helps your skin retain moisture and protects your body from outside elements. It is a type of dermatitis, a group of conditions that cause skin inflammation.
The symptoms include:
An eczema rash usually looks like a purple, brown or gray rash, depending on your skin tone, if it is on the darker shade. If you have a lighter skin tone, it may look pink, red or purple. While there is no cure, treatments are available, and now, it could also be achieved through self-talk therapy.
Cognitive Behavioral Therapy (CBT) is a psychological approach that helps individuals manage their responses to mental and physical health challenges. By identifying harmful behaviors and thought patterns, CBT guides people toward healthier coping mechanisms. Traditionally, CBT involves in-person sessions with a therapist, but researchers have now developed an online self-guided version tailored to eczema management.
ALSO READ: What Does Niacinamide Do For Your Skin?
The self-guided program teaches users to manage itching and other eczema symptoms through techniques like mindfulness and behavior modification. For instance, while scratching provides temporary relief, it can aggravate the condition. The program encourages alternative strategies, such as applying moisturizers or using meditation to diminish the urge to scratch.
To evaluate the effectiveness of this self-guided therapy, researchers conducted a 12-week study involving nearly 170 adults with eczema. Participants were randomly divided into two groups: one used the online self-guided CBT program, while the other attended traditional therapist-led sessions.
The self-guided approach required significantly less time, with participants spending an average of 16 minutes per session compared to 50 minutes in therapist-led sessions. Despite the reduced time commitment, both groups experienced comparable improvements in symptom reduction and quality of life.
These findings indicate that self-guided CBT can serve as a practical and efficient alternative to traditional therapy. This is particularly beneficial for individuals who may not have access to psychologists or prefer not to engage in face-to-face therapy. The online format allows users to work at their own pace, making eczema management more accessible.
The success of self-guided CBT in managing eczema may have broader applications in dermatology and other chronic conditions. By reducing reliance on healthcare resources, this approach could pave the way for innovative treatments across various medical fields.
This study hopes to empower patients with tools to manage their conditions independently. While eczema remains a challenging condition, self-guided therapy offers a promising avenue for relief and improved quality of life.
Credit: iStock
A team of researchers in the US has developed a nanoparticle-based technique that could make laser surgeries for kidney stones faster, safer, and potentially reduce the chances of recurrence.
Engineers from the University of Chicago and doctors from Duke University added dark nanoparticles to a common saline solution used in kidney stone laser surgeries. Their method also promised less recurrence of disease.
The research focused on laser lithotripsy, a widely used surgical method in which lasers are used to break kidney or urinary tract stones into tiny fragments that can then be removed by suctioning or pass naturally.
Traditionally, surgeons use a small video-guided laser to fragment the stones. However, achieving effective fragmentation often requires higher laser power, which generates additional heat and causes damage to the surrounding tissues.
Thus the new method “is a way to better utilize the laser energy that is already being employed,” said Po-Chun Hsu, assistant professor at the University of Chicago Pritzker School of Molecular Engineering (UChicago PME).
Hsu noted that their nanoparticle-based “nanofluid” also has the potential to enhance the performance of lasers without increasing power levels. This will effectively fragment the stones and remove the dust particles.
The study, published in the journal Advanced Science, describes an innovative saline solution that enhances the performance of existing laser systems without requiring modifications to the equipment.
By adding dark nanoparticles that absorb laser wavelengths, the solution ensures that more of the laser energy is directed at the kidney stone rather than being reflected or dispersed.
“This improves the amount of laser energy that is transmitted to and absorbed by the stones,” said corresponding author Pei Zhong, a professor of engineering at Duke University.
“Nanofluid introduces a new dimension that can influence this complex physical process, independent of the stone composition or the laser being used,” Zhong said.
Laboratory tests using artificial kidney stones showed that the nanofluid increased stone ablation efficiency by between 38 and 727 percent in spot treatments and by 26 to 75 percent in scanning treatments.
The researchers also tested the nanoparticle solution on living cells for up to 24 hours and found it to be non-toxic and safe.
In clinical settings, however, exposure would be much shorter. Laser lithotripsy is typically an outpatient procedure lasting about 30 minutes. The researchers believe that improved laser absorption could reduce the procedure time to around 10 minutes.
“If surgeries take too long, waste heat from the laser can accumulate and cause more harm than the stone removal itself,” Hsu said.
Kidney stones are hard mineral or acid salt deposits formed in the kidneys. It occurs due to concentrated urine, and causes intense, radiating back/side pain, nausea, and blood in urine.
Common causes include
Credits: Instagram
Former youth player of England, Amy Carr dies at the age of 35. England women's football team too paid tribute on her death. Carr was a former goalkeeper who played for England Under-17s and Under-19s. She was diagnosed with a brain tumor for a second time.
She was diagnosed in 2015 and raised more than £2,000 for charity by running the Dublin Marathon in 2024.
"We are heartbroken to hear that former England youth player Amy Carr has passed away aged 35," read a statement on the Lionesses' X account. "Amy, who was diagnosed with a second brain tumour in 2024, devoted her time to raising money for vital brain tumour research that could help others. She remains an inspiration to all."
Carr also played for Arsenal, Chelsea and Reading before she gained a football scholarship in the USA. Chelsea added on X: "We are saddened to learn of the passing of former Chelsea goalkeeper, Amy Carr. Our condolences are with Amy's friends and family at this time."
Before diving into the concept of a brain tumor, it is important to first understand what a tumor is. A tumor refers to an abnormal lump or mass that forms due to the uncontrolled growth of cells in the body.
A benign tumor consists of normal cells that have grown excessively to form a lump. This overgrowth may result from something going wrong in the body, but the cells themselves are not cancerous. On the other hand, a malignant tumor is made up of abnormal cells that grow uncontrollably. These are cancerous cells, and their aggressive nature can lead to serious health issues.
A brain tumor is a condition in which abnormal cells develop within any part of the brain. Similar to tumors elsewhere in the body, brain tumors can also be benign (non-cancerous) or malignant (cancerous). The presence of a tumor in the brain can interfere with normal brain function, depending on its size, type, and location.
Our bodies possess a natural healing mechanism that is crucial for survival. This repair system is activated whenever there is damage from injury, radiation from the sun, or harmful chemicals in the environment. However, this process can occasionally go wrong. When it does, small clusters of cancerous cells may begin to form. In most cases, the immune system successfully detects and destroys these abnormal cells before they grow. But in rare instances, these cancerous cells evade immune detection and continue to grow, leading to the formation of tumors or cancers.
Such abnormal growths can occur anywhere in the body. When these growths are located in the brain or spinal cord, they are referred to as Central Nervous System (CNS) tumors.
Credits: Canva
India is home to 25 per cent of the world's annual count of cervical cancer fatalities. According to the World Health Organization GLOBOCAN report of 2022, India reports over 120,000 new cases with nearly 80,000 fatalities. This is the highest death-toll worldwide from cervical cancer each year.
In India, a new case is diagnosed every four minutes, and another woman dies approximately every seven minutes. Persistent infection with high-risk HPV strains, especially types 16 and 18, is the leading cause of cervical cancer. Meanwhile, studies show that even a single dose of the HPV vaccine can provide long-lasting, potentially lifelong protection.
To combat this, India launched a nationwide campaign to vaccinate young girl against the human papillomavirus (HPV). This is also the second most common cancer among women in the country. India kicked off the nationwide campaign on 28 February. Prime Minister Narendra Modi at Ajmer city in the western state of Rajasthan inaugurated this campaign. Vaccines were made available free-of-cost at government facilities to approximately 11.5 million girls aged 14 years across the country.
Currently, approximately one in every 50 girls born in India is expected to develop cervical cancer during her lifetime, and widespread vaccination is likely to reduce this risk significantly," said Partha Basu, Head, Early Detection, Prevention & Infections Branch at the International Agency for Research on Cancer.
Cervical cancer develops in a women's cervix (uterus opening) due to abnormal cell growth, primarily caused by persistent HPV infection, a common infection that's passed through sexual contact.
When exposed to HPV, the body's immune system typically prevents the virus from causing damage however, in a small percentage of people, the virus can survive for years and pave the way for some cervical cells to become cancerous.
Treatment involves surgery, radiation, and chemotherapy, with early detection significantly improving outcomes, though it remains a major cancer in low-income countries Cervical cancer can also be prevented through vaccination and regular screening (Pap/HPV tests).
Cervical cancer has no symptoms in the early days and therefore, is hard to detect until it has spread. However, the early-stage symptoms include:
© 2024 Bennett, Coleman & Company Limited